TY - JOUR
T1 - Continuation therapies after successful treatment with electroconvulsive therapy in major depressive disorder
AU - O’Connor, Brendan J.
AU - Conway, Charles R.
N1 - Publisher Copyright:
© SLACK Incorporated.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/4
Y1 - 2019/4
N2 - Although the use of electroconvulsive therapy (ECT) predates the use of any other biologic treatment for major depressive disorder (MDD) available today, it remains the most effective treatment for the illness. Unlike antidepressant medications, ECT is commonly discontinued upon resolution of the acute depressive episode. However, relapse rates after an acute course of ECT for MDD are extremely high, and some form of continuation therapy is indicated to prevent relapse. We present findings from a literature review on various forms of continuation treatment after a successful acute course of ECT for patients with MDD. These include various forms of pharmacotherapy, ECT, and the combination of the two.
AB - Although the use of electroconvulsive therapy (ECT) predates the use of any other biologic treatment for major depressive disorder (MDD) available today, it remains the most effective treatment for the illness. Unlike antidepressant medications, ECT is commonly discontinued upon resolution of the acute depressive episode. However, relapse rates after an acute course of ECT for MDD are extremely high, and some form of continuation therapy is indicated to prevent relapse. We present findings from a literature review on various forms of continuation treatment after a successful acute course of ECT for patients with MDD. These include various forms of pharmacotherapy, ECT, and the combination of the two.
UR - http://www.scopus.com/inward/record.url?scp=85065980440&partnerID=8YFLogxK
U2 - 10.3928/00485713-20190314-01
DO - 10.3928/00485713-20190314-01
M3 - Article
AN - SCOPUS:85065980440
SN - 0048-5713
VL - 49
SP - 164
EP - 168
JO - Psychiatric Annals
JF - Psychiatric Annals
IS - 4
ER -